The discovery of MK-0674, an orally bioavailable cathepsin K inhibitor
Authors:
- Elise IsabelEIElise Isabel
- Kevin P. BatemanKBKevin P. Bateman
- Nathalie ChauretNCNathalie Chauret
- Wanda CromlishWCWanda Cromlish
- Sylvie DesmaraisSDSylvie Desmarais
- Le T. DuongLDLe T. Duong
- Jean-Pierre FalgueyretJFJean-Pierre Falgueyret
- Jacques Yves GauthierJGJacques Yves Gauthier
- Sonia LamontagneSLSonia Lamontagne
- Cheuk K. LauCLCheuk K. Lau
- Serge LégerSLSerge Léger
- Tammy LeRicheTLTammy LeRiche
- 1 February 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (3) , 887-892
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cathepsin K inhibitors for osteoporosis and potential off-target effectsExpert Opinion on Investigational Drugs, 2009
- Bone health and osteoporosis in postmenopausal womenBest Practice & Research Clinical Obstetrics & Gynaecology, 2009
- A Practical Enantioselective Synthesis of Odanacatib, a Potent Cathepsin K Inhibitor, via Triflate Displacement of an α-Trifluoromethylbenzyl TriflateThe Journal of Organic Chemistry, 2009
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin KBioorganic & Medicinal Chemistry Letters, 2008
- Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025Journal of Bone and Mineral Research, 2007
- Diastereoselective Reductive Amination of Aryl Trifluoromethyl Ketones and α‐Amino EstersAngewandte Chemie International Edition, 2007
- Role of Cathepsin K in Normal Joints and in the Development of ArthritisCurrent Drug Targets, 2007
- A Concise Synthesis of (S)-γ-Fluoroleucine Ethyl EsterSynlett, 2005
- Unprecedented Catalytic Asymmetric Reduction of N−H IminesOrganic Letters, 2004
- How do osteoclasts resorb bone?Materials Science and Engineering: C, 1998